Panel Headliner Stage track
UK Calling: Is Britain Still an Attractive Hub for Life Science Companies?
Mon, Nov 16, 2026 · 4:15–5:00 PM GMT Old Billingsgate
About this session
The UK has long positioned itself as Europe's leading life science hub, boasting world-class research institutions, deep clinical expertise, and access to international capital markets. But as competition intensifies, the question remains: does the UK still offer a compelling value proposition for biotech and medtech companies? This panel brings together investors, entrepreneurs, and ecosystem leaders to candidly assess the UK's strengths and weaknesses—from talent availability and regulatory environment to funding access and exit opportunities Evaluating the UK's access to scientific talent,…
